337 related articles for article (PubMed ID: 18166795)
21. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
Schwartz LB
Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
[TBL] [Abstract][Full Text] [Related]
22. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
Pozdnyakova O; Kondtratiev S; Li B; Charest K; Dorfman DM
Am J Clin Pathol; 2012 Sep; 138(3):416-24. PubMed ID: 22912359
[TBL] [Abstract][Full Text] [Related]
23. Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.
Zanotti R; Bonifacio M; Lucchini G; Sperr WR; Scaffidi L; van Anrooij B; Oude Elberink HN; Rossignol J; Hermine O; Gorska A; Lange M; Hadzijusufovic E; Miething C; Müller S; Perkins C; Shomali W; Elena C; Illerhaus A; Jawhar M; Parente R; Caroppo F; Solomianyi O; Zink A; Mattsson M; Yavuz AS; Panse J; Varkonyi J; Doubek M; Sabato V; Breynaert C; Vucinic V; Schug T; Hägglund H; Wortmann F; Brockow K; Angelova-Fischer I; Belloni Fortina A; Triggiani M; Reiter A; Hartmann K; Malcovati L; Gotlib J; Shoumariyeh K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Bonadonna P; Valent P
Leukemia; 2022 Feb; 36(2):516-524. PubMed ID: 34545185
[TBL] [Abstract][Full Text] [Related]
24. Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.
Böhm A; Födinger M; Wimazal F; Haas OA; Mayerhofer M; Sperr WR; Esterbauer H; Valent P
J Allergy Clin Immunol; 2007 Jul; 120(1):192-9. PubMed ID: 17451799
[TBL] [Abstract][Full Text] [Related]
25. [Systemic mastocytosis. Study of 14 cases].
García-Erce JA; Giraldo P; de Vicente P; Alvarez R; Losfablos F; Velilla J; Mayayo P; Rubio-Félix D; Giralt M
Med Clin (Barc); 1998 Oct; 111(13):499-502. PubMed ID: 9859067
[TBL] [Abstract][Full Text] [Related]
26. Multimodal therapy for vertebral involvement of systemic mastocytosis.
Krüger A; Hamann C; Brendel C; Ramaswamy A; Schnabel M; Neubauer A; Hofbauer LC
Spine (Phila Pa 1976); 2009 Aug; 34(17):E626-8. PubMed ID: 19644322
[TBL] [Abstract][Full Text] [Related]
27. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
[TBL] [Abstract][Full Text] [Related]
28. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
Butterfield JH; Weiler CR
Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
[TBL] [Abstract][Full Text] [Related]
29. Presentation of untreated systemic mastocytosis as recurrent, pulseless-electrical-activity cardiac arrests resistant to cardiac pacemaker.
Butterfield JH; Weiler CR
Int Arch Allergy Immunol; 2014; 163(2):130-4. PubMed ID: 24335343
[TBL] [Abstract][Full Text] [Related]
30. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.
Carter MC; Clayton ST; Komarow HD; Brittain EH; Scott LM; Cantave D; Gaskins DM; Maric I; Metcalfe DD
J Allergy Clin Immunol; 2015 Dec; 136(6):1673-1679.e3. PubMed ID: 26044856
[TBL] [Abstract][Full Text] [Related]
31. Urinary N-methylhistamine as an indicator of bone marrow involvement in mastocytosis.
Oranje AP; Mulder PG; Heide R; Tank B; Riezebos P; van Toorenenbergen AW
Clin Exp Dermatol; 2002 Sep; 27(6):502-6. PubMed ID: 12372095
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of indolent mastocytosis in adults.
Kors JW; Van Doormaal JJ; Breukelman H; Van Voorst Vader PC; De Monchy JG
J Intern Med; 1996 Feb; 239(2):157-64. PubMed ID: 8568484
[TBL] [Abstract][Full Text] [Related]
33. Systemic mastocytosis: a diagnostic challenge.
Bateman HE; Shroff V; Centeno LV; Bielory L
Ann Allergy Asthma Immunol; 1995 May; 74(5):379-86. PubMed ID: 7749967
[TBL] [Abstract][Full Text] [Related]
34. Indolent systemic mastocytosis: a case and review of the current available treatment options.
Lee Y; Wood P; Soyer HP
Dermatol Online J; 2013 Jun; 19(6):18562. PubMed ID: 24011312
[TBL] [Abstract][Full Text] [Related]
35. Indolent systemic mastocytosis associated with atypical small lymphocytic lymphoma: a rare form of concomitant lymphoproliferative disease.
Hauswirth AW; Födinger M; Fritz M; Müllauer L; Simonitsch-Klupp I; Streubel B; Chott A; Sperr WR; Jäger U; Valent P
Hum Pathol; 2008 Jun; 39(6):917-24. PubMed ID: 18448146
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of systemic mastocytosis with high-dose interferon-alfa: long-term follow-up of a case.
Butterfield JH; Tefferi A; Kozuh GF
Leuk Res; 2005 Feb; 29(2):131-4. PubMed ID: 15607359
[TBL] [Abstract][Full Text] [Related]
37. [Systemic mastocytosis as a cause of osteoporosis].
Kemink SA; Smals AG; Kloppenborg PW
Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1277-9. PubMed ID: 8700283
[TBL] [Abstract][Full Text] [Related]
38. The measurement of leukotrienes in urine as diagnostic option in systemic mastocytosis.
Raithel M; Zopf Y; Kimpel S; Naegel A; Molderings GJ; Buchwald F; Schultis HW; Kressel J; Hahn EG; Konturek P
J Physiol Pharmacol; 2011 Aug; 62(4):469-72. PubMed ID: 22100848
[TBL] [Abstract][Full Text] [Related]
39. Case report: pathologic long bone fracture in a patient with systemic mastocytosis.
King JJ; Crawford EA; Iwenofu OH; Fox EJ
Clin Orthop Relat Res; 2007 Jun; 459():263-9. PubMed ID: 17327804
[TBL] [Abstract][Full Text] [Related]
40. Aggressive systemic mastocytosis presenting with hepatic cholestasis.
Kupfer SS; Hart J; Mohanty SR
Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):901-5. PubMed ID: 17873616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]